Learn how melanoma impacts African Americans, highlighting detection challenges, survival disparities, and prevention ...

Kelly Heather, 38, ended up needing brain surgery for a tumor — and it started as a discolored line on her fingernail ...

Research has introduced daromun, therapeutic vaccines, and novel combinations for metastatic melanoma, reshaping the ...

Risk for 20-year melanoma-related death increases significantly for patients with primary tumors of 0.8 to 1.0 mm in ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live longer and better destroy cancer cells in a mouse model of melanoma compared ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.

After treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear. These are cells that do ...

The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have ...

Erasca is a biotech company focused on developing therapies for RAS/MAPK pathway-driven cancers with a strong financial ...

Ray Price may have beaten melanoma, but his battle against the cancer doesn’t stop there. The Parramatta Eels legend and dual ...